TB by Non-HIV Medical Risk, Reporting Areas

About

This table describes the number of cases of tuberculosis (TB) disease with the following non-HIV medical risk factors: diabetes, post-organ transplantation, TNF-a inhibitors, end-state renal disease, viral hepatitis, or other immunocompromised condition or therapy by U.S. reporting area in 2023.

Key Highlights

  • In 2024, non-HIV medical risk factors reported for persons with TB were diabetes (22%), non-HIV immunosuppression (6%), viral hepatitis (3%), end-stage renal disease (2%), treatment with a TNF-alpha inhibitor (2%), and post-organ transplantation (1%).

Data Table

Non-HIV Medical Risk Factors for Tuberculosis: Reporting Areas, 2024

CDC describes cases of TB disease by non-HIV medical risk factors and reporting area in 2024.
Reporting area Total cases1 Diabetes mellitus Post-organ transplantation TNF-α inhibitors2 End-stage renal disease Viral hepatitis3 Non-HIV immunosuppression4
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
United States5 10,388 2,275 (21.9) 73 (0.7) 154 (1.5) 244 (2.3) 331 (3.2) 663 (6.4)
Alabama 90 15 (16.7) 0 (0.0) 0 (0.0) 2 (2.2) 6 (6.7) 8 (8.9)
Alaska 91 8 (8.8) 1 (1.1) 2 (2.2) 1 (1.1) 1 (1.1) 2 (2.2)
Arizona 210 54 (25.7) 1 (0.5) 2 (1.0) 3 (1.4) 6 (2.9) 17 (8.1)
Arkansas 119 21 (17.6) 0 (0.0) 0 (0.0) 0 (0.0) 4 (3.4) 11 (9.2)
California 2,109 657 (31.2) 18 (0.9) 49 (2.3) 81 (3.8) 92 (4.4) 126 (6.0)
Colorado 78 17 (21.8) 0 (0.0) 1 (1.3) 1 (1.3) 1 (1.3) 2 (2.6)
Connecticut 87 17 (19.5) 1 (1.1) 1 (1.1) 2 (2.3) 2 (2.3) 2 (2.3)
Delaware 24 2 (8.3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
District of Columbia 33 3 (9.1) 0 (0.0) 0 (0.0) 3 (9.1) 0 (0.0) 0 (0.0)
Florida 675 101 (15.0) 3 (0.4) 11 (1.6) 8 (1.2) 18 (2.7) 65 (9.6)
Georgia 254 67 (26.4) 2 (0.8) 2 (0.8) 6 (2.4) 10 (3.9) 29 (11.4)
Hawaii 117 55 (47.0) 0 (0.0) 0 (0.0) 8 (6.8) 4 (3.4) 5 (4.3)
Idaho 22 6 (27.3) 0 (0.0) 1 (4.5) 0 (0.0) 1 (4.5) 1 (4.5)
Illinois 352 74 (21.0) 5 (1.4) 4 (1.1) 9 (2.6) 4 (1.1) 22 (6.3)
Indiana 136 22 (16.2) 1 (0.7) 1 (0.7) 2 (1.5) 4 (2.9) 9 (6.6)
Iowa 47 5 (10.6) 0 (0.0) 2 (4.3) 1 (2.1) 3 (6.4) 1 (2.1)
Kansas 114 22 (19.3) 1 (0.9) 0 (0.0) 2 (1.8) 2 (1.8) 10 (8.8)
Kentucky 93 14 (15.1) 1 (1.1) 1 (1.1) 1 (1.1) 0 (0.0) 3 (3.2)
Louisiana 116 24 (20.7) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.9) 16 (13.8)
Maine 39 1 (2.6) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.6) 0 (0.0)
Maryland 220 41 (18.6) 3 (1.4) 5 (2.3) 1 (0.5) 6 (2.7) 12 (5.5)
Massachusetts 254 25 (9.8) 1 (0.4) 10 (3.9) 8 (3.1) 19 (7.5) 12 (4.7)
Michigan 165 32 (19.4) 0 (0.0) 3 (1.8) 5 (3.0) 5 (3.0) 19 (11.5)
Minnesota 194 35 (18.0) 0 (0.0) 2 (1.0) 3 (1.5) 10 (5.2) 16 (8.2)
Mississippi 49 11 (22.4) 3 (6.1) 1 (2.0) 5 (10.2) 1 (2.0) 7 (14.3)
Missouri 85 15 (17.6) 1 (1.2) 0 (0.0) 1 (1.2) 3 (3.5) 1 (1.2)
Montana 6 1 (16.7) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Nebraska 41 5 (12.2) 0 (0.0) 1 (2.4) 2 (4.9) 2 (4.9) 2 (4.9)
Nevada 75 24 (32.0) 1 (1.3) 0 (0.0) 1 (1.3) 0 (0.0) 5 (6.7)
New Hampshire 12 2 (16.7) 0 (0.0) 0 (0.0) 1 (8.3) 1 (8.3) 2 (16.7)
New Jersey 342 79 (23.1) 4 (1.2) 5 (1.5) 11 (3.2) 7 (2.0) 27 (7.9)
New Mexico 40 13 (32.5) 0 (0.0) 3 (7.5) 1 (2.5) 0 (0.0) 6 (15.0)
New York State6 250 58 (23.2) 4 (1.6) 6 (2.4) 8 (3.2) 4 (1.6) 38 (15.2)
New York City 833 137 (16.4) 1 (0.1) 0 (0.0) 10 (1.2) 22 (2.6) 49 (5.9)
North Carolina 249 53 (21.3) 2 (0.8) 6 (2.4) 6 (2.4) 6 (2.4) 19 (7.6)
North Dakota 11 1 (9.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Ohio 198 34 (17.2) 3 (1.5) 0 (0.0) 3 (1.5) 2 (1.0) 6 (3.0)
Oklahoma 65 17 (26.2) 0 (0.0) 2 (3.1) 2 (3.1) 4 (6.2) 6 (9.2)
Oregon 87 18 (20.7) 0 (0.0) 4 (4.6) 4 (4.6) 2 (2.3) 5 (5.7)
Pennsylvania 228 42 (18.4) 2 (0.9) 4 (1.8) 7 (3.1) 5 (2.2) 19 (8.3)
Rhode Island 23 5 (21.7) 0 (0.0) 1 (4.3) 0 (0.0) 1 (4.3) 1 (4.3)
South Carolina 83 16 (19.3) 0 (0.0) 2 (2.4) 2 (2.4) 3 (3.6) 4 (4.8)
South Dakota 12 3 (25.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (8.3) 1 (8.3)
Tennessee 163 32 (19.6) 2 (1.2) 4 (2.5) 3 (1.8) 4 (2.5) 13 (8.0)
Texas 1,279 251 (19.6) 4 (0.3) 6 (0.5) 14 (1.1) 35 (2.7) 37 (2.9)
Utah 51 12 (23.5) 1 (2.0) 2 (3.9) 3 (5.9) 2 (3.9) 2 (3.9)
Vermont 4 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Virginia 225 54 (24.0) 5 (2.2) 2 (0.9) 6 (2.7) 7 (3.1) 14 (6.2)
Washington 257 58 (22.6) 2 (0.8) 7 (2.7) 7 (2.7) 15 (5.8) 10 (3.9)
West Virginia 8 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Wisconsin 69 14 (20.3) 0 (0.0) 1 (1.4) 0 (0.0) 3 (4.3) 1 (1.4)
Wyoming 4 2 (50.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (25.0) 0 (0.0)
American Samoa 11 4 (36.4) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Federated States of Micronesia 143 11 (7.7) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Guam 60 20 (33.3) 0 (0.0) 0 (0.0) 2 (3.3) 0 (0.0) 1 (1.7)
Republic of the Marshall Islands 94 40 (42.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.1)
Northern Mariana Islands 10 3 (30.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Puerto Rico 13 4 (30.8) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Republic of Palau 4 2 (50.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
U.S. Virgin Islands 1 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)

1One person might have more than one risk factor, therefore the total number of risk factors may be greater than the number of cases.

2TNF, tumor necrosis factor.

3Diagnosed with hepatitis B or C (acute or chronic).

4Excludes diabetes mellitus, post-organ transplantation, TNF-α inhibitors, end-stage renal disease, and viral hepatitis.

5American Samoa, Federated States of Micronesia, Guam, Republic of the Marshall Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Islands are not included in the U.S. totals and percentages.

6Excludes New York City.

Notes

Data for all years are updated through July 10, 2025.

Resources

Print
Content Source:
National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention; About Division of Tuberculosis Elimination